Regular paper5-S-Cysteinyldopa (cas 19641-92-0), a diffusible product of melanocyte activity, is an efficient inhibitor of hydroxylation/oxidation reactions induced by the Fenton system
-
Add time:09/07/2019 Source:sciencedirect.com
Interest in 5-S-cysteinyldopa (5-S-CD), a major excretion product of normal and malignant melanocytes, has traditionally concentrated on its significance as a biosynthetic precursor of pheomelanins, the characteristic pigments of red hair, and as a specific biochemical marker for monitoring melanoma progression. The present study shows that 5-S-CD is a potent inhibitor of hydroxylation/oxidation reactions mediated by hydrogen peroxide and the Fe2+/EDTA complex under both aerobic and anaerobic conditions. The inhibitory effect of 5-S-CD, as determined by the deoxyribose and salicylic acid assays in phosphate buffer (pH 7.4), is much stronger than that of dopa, acetylsalicylic acid and mannitol, increases with increasing ligand-to-metal ratio, and is inversely proportional to the concentration of EDTA present in the Fenton system. Spectrophotometric evidence and competition experiments indicate that 5-S-CD forms a chelate complex with ferric ions (λmax = 500 nm at pH 7.4), which may account for both an altered production radicals by the Fenton reagent and a site-specific localization of oxidative damage on the chelate complex itself.
We also recommend Trading Suppliers and Manufacturers of Cysteinyldopa (cas 19641-92-0). Pls Click Website Link as below: cas 19641-92-0 suppliers
Prev:A pulse radiolysis investigation of the oxidation of the melanin precursors 3,4-dihydroxyphenylalanine (dopa) and the Cysteinyldopa (cas 19641-92-0)s
Next:Chapter Nine - Structural mass spectrometry approaches to study the 20S proteasome) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A pulse radiolysis investigation of the oxidation of the melanin precursors 3,4-dihydroxyphenylalanine (dopa) and the Cysteinyldopa (cas 19641-92-0)s09/06/2019
- Clinical investigation5-S-Cysteinyldopa (cas 19641-92-0) as Diagnostic Tumor Marker for Uveal Malignant Melanoma09/05/2019
- Characterisation of 1,4-benzothiazine intermediates in the oxidative conversion of 5-S-Cysteinyldopa (cas 19641-92-0) to pheomelanins09/04/2019
- General paperNon-enzymic oxidation of Cysteinyldopa (cas 19641-92-0) catalyzed by metallic ions09/03/2019
- Development of a mass spectrometry method for the determination of a melanoma biomarker, 5-S-Cysteinyldopa (cas 19641-92-0), in human plasma using solid phase extraction for sample clean-up09/02/2019
- Presence of Cysteinyldopa (cas 19641-92-0) in the mature bovine eye09/01/2019
- The first expedient entry to the human melanogen 2-S-Cysteinyldopa (cas 19641-92-0) exploiting the anomalous regioselectivity of 3,4-dihydroxycinnamic acid–thiol conjugation08/31/2019
- Case reportTreatment of Primary Melanoma of the Lung Monitored by 5-S-Cysteinyldopa (cas 19641-92-0) Levels08/30/2019
- The pheomelanin precursor 5-S-Cysteinyldopa (cas 19641-92-0) protects melanocytes from membrane damage induced by ultraviolet A radiation08/29/2019


